Nuo Therapeutics

(OTC) AURX

Current Price$0.99

Market Cap$47.92M

Since IPO (2017)-51%

5 Year+32%

1 Year-36%

1 Month-24%

Nuo Therapeutics Financials at a Glance

Market Cap

$47.92M

Revenue (TTM)

$4.13M

Net Income (TTM)

-$2.38M

EPS (TTM)

-$0.05

P/E Ratio

-19.80

Dividend

$0.00

Beta (Volatility)

-37.83 (Low)

Dividend

$0.00

Beta (Volatility)

-37.83 (Low)

Price

$0.99

Volume

1,360

Open

$0.99

Price

$0.99

Volume

1,360

Open

$0.99

Previous Close

$0.99

Daily Range

$0.99 - $0.99

52-Week Range

$0.94 - $3.23

Dividend

$0.00

Beta (Volatility)

-37.83 (Low)

Price

$0.99

Volume

1,360

Open

$0.99

Previous Close

$0.99

Daily Range

$0.99 - $0.99

52-Week Range

$0.94 - $3.23

AURX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nuo Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

David Emerson Jorden, CFA, MBA

Website

www.nuot.com

Headquarters

Houston, TX 77054, US

AURX Financials

Key Financial Metrics (TTM)

Gross Margin

65%

Operating Margin

-54%

Net Income Margin

-58%

Return on Equity

-1032%

Return on Capital

-4%

Return on Assets

-1%

Earnings Yield

-5.05%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$47.92M

Shares Outstanding

48.41M

Volume

1.36K

Avg. Volume

4.62K

Financials (TTM)

Gross Profit

$2.22M

Operating Income

-$2.52M

EBITDA

-$2.36M

Operating Cash Flow

-$864.97K

Capital Expenditure

-$274.76K

Free Cash Flow

-$1.14M

Cash & ST Invst.

$548.95K

Total Debt

$97.35K

Nuo Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$1.30M

+168.8%

Gross Profit

$849.73K

+133.9%

Gross Margin

65.26%

N/A

Market Cap

$47.92M

N/A

Market Cap/Employee

$5.32M

N/A

Employees

N/A

Net Income

-$618.47K

+17.1%

EBITDA

-$405.27K

+45.6%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

-$635.12K

-587.0%

Accounts Receivable

$873.67K

+215.9%

Inventory

$248.54K

+150.6%

Long Term Debt

$820.00K

+938.6%

Short Term Debt

$78.95K

-42.9%

Return on Assets

-1.23%

N/A

Return on Invested Capital

-3.85%

N/A

Free Cash Flow

-$785.12K

-244.3%

Operating Cash Flow

-$784.27K

-43073.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

IUGNFImugene Limited

IUGNFImugene Limited$0.09-5.49%

VSBCVitaSpring Biomedical Co. Ltd.

VSBCVitaSpring Biomedical Co. Ltd.$0.01+0.00%

RCELAVITA Medical, Inc.

RCELAVITA Medical, Inc.$4.40+4.64%

SPHRYStarpharma Holdings Limited

SPHRYStarpharma Holdings Limited$4.76-1.35%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

IUSBiShares Trust - iShares Core Universal Usd Bond ETF

IUSBiShares Trust - iShares Core Universal Usd Bond ETF$46.17+0.00%

CZRCaesars Entertainment

CZRCaesars Entertainment$29.06+0.01%

IALTBlackrock ETF Trust - iShares Systematic Alternatives Active ETF

IALTBlackrock ETF Trust - iShares Systematic Alternatives Active ETF$28.24+0.00%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$38.55-0.02%

ATPCAgape Atp

ATPCAgape Atp$6.78+1.38%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$83.52+0.02%

SIDUSidus Space

SIDUSidus Space$5.15-0.15%

Questions About AURX

What is the current price of Nuo Therapeutics?

Nuo Therapeutics is trading at $0.99 per share.

What is the 52-week range for Nuo Therapeutics?

Over the past 52 weeks, Nuo Therapeutics has traded between $0.94 and $3.23.

How much debt does Nuo Therapeutics have?

As of the most recent reporting period, Nuo Therapeutics reported total debt of $1.10M.

How much cash does Nuo Therapeutics have on hand?

Nuo Therapeutics reported $263.83K in cash and cash equivalents in its most recent financial results.

What is Nuo Therapeutics’s dividend yield?

Nuo Therapeutics does not currently have a dividend yield.

Nuo Therapeutics

Nuo Therapeutics Financials at a Glance

AURX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Nuo Therapeutics

AURX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Nuo Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About AURX

What is the current price of Nuo Therapeutics?

What is the 52-week range for Nuo Therapeutics?

How much debt does Nuo Therapeutics have?

How much cash does Nuo Therapeutics have on hand?

What is Nuo Therapeutics’s dividend yield?

Premium Investing Services